KALV icon

KalVista Pharmaceuticals

25 hedge funds and large institutions have $61.6M invested in KalVista Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

3% less capital invested

Capital invested by funds: $63.2M → $61.6M (-$1.62M)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.81M
2 +$429K
3 +$389K
4
DZ Bank
DZ Bank
Germany
+$385K
5
DS
DRW Securities
Illinois
+$28.4K

Top Sellers

1 -$1.76M
2 -$430K
3 -$385K
4
Goldman Sachs
Goldman Sachs
New York
-$151K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$77.3K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$24.5M
2
$13.7M
3
$8.53M
4
$3.13M
5
$3.01M
6
$2.85M
7
$2.17M
8
$1.11M
9
$429K
10
$412K
11
$409K
12
$389K
13
$385K
14
$199K
15
$196K
16
$142K
17
$50K
18
$44K
19
$12K
20
$5K
21
$3K
22
$2K
23
$1K
24
$1K
25